U.K. ultrasound and patient monitoring firm Kontron Instruments has gone into receivership, according to the administrator of its accounts, international accounting firm KPMG. KPMG attributed the company's failure to the reduction in healthcare spending
U.K. ultrasound and patient monitoring firm Kontron Instruments has gone into receivership, according to the administrator of its accounts, international accounting firm KPMG. KPMG attributed the company's failure to the reduction in healthcare spending in Europe, 1998's downturn in the Asian market, and increased competition in the overall healthcare market. Watford, U.K.-based Kontron reported revenues of about $24 million for the 12 months ended June 30, 1997.
The company's assets include intellectual property rights to its monitoring products, an electronic assembly plant and its machinery, raw materials, and stock. KPMG seeks to sell Kontron as a going concern and expects to find a buyer shortly, according to Paul Jeffery, administrative receiver for KPMG in Hertfordshire, U.K. Kontron owes roughly $8 million to its 450 creditors.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.